Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

WORK Medical Technology (WOK) Receivables (2023 - 2025)

Historic Receivables for WORK Medical Technology (WOK) over the last 3 years, with Q3 2025 value amounting to $11.4 million.

  • WORK Medical Technology's Receivables rose 16176.19% to $11.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.4 million, marking a year-over-year increase of 16176.19%. This contributed to the annual value of $11.4 million for FY2025, which is 16176.19% up from last year.
  • As of Q3 2025, WORK Medical Technology's Receivables stood at $11.4 million, which was up 16176.19% from $2.3 million recorded in Q1 2025.
  • In the past 5 years, WORK Medical Technology's Receivables ranged from a high of $11.4 million in Q3 2025 and a low of $2.3 million during Q1 2025
  • In the last 3 years, WORK Medical Technology's Receivables had a median value of $4.4 million in 2023 and averaged $5.6 million.
  • Its Receivables has fluctuated over the past 5 years, first plummeted by 140.83% in 2024, then skyrocketed by 16176.19% in 2025.
  • Over the past 3 years, WORK Medical Technology's Receivables (Quarter) stood at $4.4 million in 2023, then dropped by 1.41% to $4.4 million in 2024, then surged by 161.76% to $11.4 million in 2025.
  • Its last three reported values are $11.4 million in Q3 2025, $2.3 million for Q1 2025, and $4.4 million during Q3 2024.